[go: up one dir, main page]

WO2009054401A1 - 複素芳香族化合物を有効成分とする抗ウイルス剤 - Google Patents

複素芳香族化合物を有効成分とする抗ウイルス剤 Download PDF

Info

Publication number
WO2009054401A1
WO2009054401A1 PCT/JP2008/069122 JP2008069122W WO2009054401A1 WO 2009054401 A1 WO2009054401 A1 WO 2009054401A1 JP 2008069122 W JP2008069122 W JP 2008069122W WO 2009054401 A1 WO2009054401 A1 WO 2009054401A1
Authority
WO
WIPO (PCT)
Prior art keywords
atom
nitrogen atom
viral agent
independently represent
active ingredient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2008/069122
Other languages
English (en)
French (fr)
Inventor
Masanori Baba
Yuichi Hashimoto
Hiroshi Aoyama
Kumiko Sako
Shinichi Sato
Katsuyuki Nagai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kagoshima University NUC
Oncolys Biopharma Inc
Original Assignee
Kagoshima University NUC
Oncolys Biopharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kagoshima University NUC, Oncolys Biopharma Inc filed Critical Kagoshima University NUC
Priority to JP2009538227A priority Critical patent/JP5526339B2/ja
Priority to US12/739,795 priority patent/US20100256379A1/en
Publication of WO2009054401A1 publication Critical patent/WO2009054401A1/ja
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/86—Carbazoles; Hydrogenated carbazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/91—Dibenzofurans; Hydrogenated dibenzofurans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)

Abstract

　本発明は、次式(I)： 【化１】 (式中、 Xは、CH、窒素原子、酸素原子又は硫黄原子であり、 Y及びZは、同一又は異なり、窒素原子又はC-R8であって、少なくとも一方は窒素原子であり、 R1～R8は、同一又は異なり、水素原子、直鎖C1-10-炭化水素基、水酸基又は置換若しくは非置換のベンジル基であり、ただし、Xが酸素原子又は硫黄原子の場合には、R5は存在しない)、若しくは 　次式(II)： 【化２】 (式中、 X'は、CH又は窒素原子であり、 Y'及びZ'は、同一又は異なり、窒素原子、N-R9又はC-R8であって、少なくとも一方は窒素原子又はN-R9であり、 R1～R4及びR6～R8は、前記と同一であり、 R9は、水素原子、直鎖C1-10-炭化水素基、水酸基又は置換若しくは非置換のベンジル基であり、 C環は、点線部分に最多二重結合を有する) で示される化合物又はその薬学的に許容される塩を含有する抗ウイルス剤に関する。
PCT/JP2008/069122 2007-10-26 2008-10-22 複素芳香族化合物を有効成分とする抗ウイルス剤 Ceased WO2009054401A1 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2009538227A JP5526339B2 (ja) 2007-10-26 2008-10-22 複素芳香族化合物を有効成分とする抗ウイルス剤
US12/739,795 US20100256379A1 (en) 2007-10-26 2008-10-22 Anti-viral agent containing heterocyclic aromatic compound as active ingredient

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2007-279648 2007-10-26
JP2007279648 2007-10-26
JP2008050771 2008-02-29
JP2008-050771 2008-02-29

Publications (1)

Publication Number Publication Date
WO2009054401A1 true WO2009054401A1 (ja) 2009-04-30

Family

ID=40579505

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/069122 Ceased WO2009054401A1 (ja) 2007-10-26 2008-10-22 複素芳香族化合物を有効成分とする抗ウイルス剤

Country Status (3)

Country Link
US (1) US20100256379A1 (ja)
JP (1) JP5526339B2 (ja)
WO (1) WO2009054401A1 (ja)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120178759A1 (en) * 2009-07-28 2012-07-12 Commissariat A L'energie Atomique Et Aux Ene Alt Condensed pyridine derivatives useful as potent inhibitors of the protein kinase ck2
CN110759923A (zh) * 2018-07-26 2020-02-07 上海医药工业研究院 嘧啶并吡咯并哒嗪衍生物、其中间体、制备方法、药物组合物和用途
WO2022194087A1 (en) * 2021-03-16 2022-09-22 Cullgen (Shanghai) , Inc. Modified proteins and protein binders

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN120717939B (zh) * 2025-08-28 2025-11-07 南开大学 一种氮杂环生物碱及其在防治植物病毒方面的应用

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005037791A1 (en) * 2003-10-15 2005-04-28 Chiron Corporation Compositions and methods for viral inhibition
WO2006118607A2 (en) * 2004-11-22 2006-11-09 Smithkline Beecham Corporation Hcv inhibitors with carbazole structure
WO2006121466A2 (en) * 2004-11-22 2006-11-16 Smithkline Beecham Corporation Hcv inhibitors
WO2006121467A2 (en) * 2004-11-22 2006-11-16 Smithkline Beecham Corporation Tetrahydrocarbazole derivatives for treating flaviridae viruses

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1268771A (en) * 1968-03-15 1972-03-29 Glaxo Lab Ltd Azacarbazoles
JPS60100576A (ja) * 1983-07-25 1985-06-04 ザ　ボ−ドオブトラステイ−ズ　オブ　ザ　ユニバ−シテイ　オブ　イリノイズ 海洋被嚢類からの抗ビ−ルス性ユ−ジストミン類
EP1590349A1 (en) * 2003-01-27 2005-11-02 Pfizer Inc. Hiv-integrase inhibitors, pharmaceutical compositions, and methods for their use

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005037791A1 (en) * 2003-10-15 2005-04-28 Chiron Corporation Compositions and methods for viral inhibition
WO2006118607A2 (en) * 2004-11-22 2006-11-09 Smithkline Beecham Corporation Hcv inhibitors with carbazole structure
WO2006121466A2 (en) * 2004-11-22 2006-11-16 Smithkline Beecham Corporation Hcv inhibitors
WO2006121467A2 (en) * 2004-11-22 2006-11-16 Smithkline Beecham Corporation Tetrahydrocarbazole derivatives for treating flaviridae viruses

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120178759A1 (en) * 2009-07-28 2012-07-12 Commissariat A L'energie Atomique Et Aux Ene Alt Condensed pyridine derivatives useful as potent inhibitors of the protein kinase ck2
JP2013500325A (ja) * 2009-07-28 2013-01-07 コミサリア ア レネルジィ アトミーク エ オ ゼネ ルジイ アルテアナティーフ プロテインキナーゼｃｋ２の強力阻害剤として有用な縮合ピリジン誘導体
US8686144B2 (en) * 2009-07-28 2014-04-01 Commissariat a l'Energie Atomique et aux Energie Alternative Condensed pyridine derivatives useful as potent inhibitors of the protein kinase CK2
CN110759923A (zh) * 2018-07-26 2020-02-07 上海医药工业研究院 嘧啶并吡咯并哒嗪衍生物、其中间体、制备方法、药物组合物和用途
CN110759923B (zh) * 2018-07-26 2022-08-30 上海医药工业研究院有限公司 嘧啶并吡咯并哒嗪衍生物、其中间体、制备方法、药物组合物和用途
WO2022194087A1 (en) * 2021-03-16 2022-09-22 Cullgen (Shanghai) , Inc. Modified proteins and protein binders

Also Published As

Publication number Publication date
JP5526339B2 (ja) 2014-06-18
US20100256379A1 (en) 2010-10-07
JPWO2009054401A1 (ja) 2011-03-03

Similar Documents

Publication Publication Date Title
EP1426366A4 (en) THIAZOLIDE DERIVATIVES AND THEIR MEDICAL USE
TW200635930A (en) Bicyclic pyrrole derivatives
AU2268302A (en) Inhibitors against the production and release of inflammatory cytokines
WO2006049835A3 (en) Indole and benzimidazole derivatives
MY172034A (en) Intermediate for producing bicyclic ?-amino acid derivative
MY154772A (en) Harmful arthropod control composition, and fused heterocyclic compound
EP2090570A4 (en) IMIDAZOLE DERIVATIVE
MX2012007060A (es) Compuesto heterociclico conteniendo nitrogeno y fungicida para el uso en agricultura y jardineria.
EP1953154A4 (en) CINNAMIDE COMPOUNDS OF MORPHOLINE TYPE
EP1864665A4 (en) IMMUNOSUPPRESSIVE AGENT AND ANTI-TUMOR AGENT COMPRISING A HETEROCYCLIC COMPOUND AS ACTIVE INGREDIENT
WO2008096829A1 (ja) ３環系化合物
ZA200803414B (en) Novel dihydropseudoerythromycin derivatives
AR057894A1 (es) Derivados de tiofeno
EP1724258A4 (en) HETEROARYLPHENYLUREE DERIVATIVE
WO2008108378A3 (en) Bicyclic oxomorpholine derivative
WO2008096841A1 (ja) 二量化シクロ誘導体
EP1650206A4 (en) PHENYLAZOLE COMPOUNDS, PROCESS FOR THEIR PRODUCTION AND ANTIOXIDANTS
WO2008093691A1 (ja) 網膜神経又は視神経の保護剤
WO2009054401A1 (ja) 複素芳香族化合物を有効成分とする抗ウイルス剤
WO2003004497A1 (en) Novel heterocyclic compound
WO2008093838A1 (ja) スルファモイル基を有するピリジルイミダゾリジン誘導体、およびその医薬としての使用
WO2008021975A3 (en) Therapeutic lactams
WO2004050035A3 (en) Benzimidazoles and analogs thereof as antivirals
MXPA04002570A (es) Compuestos que inhiben la liberacion de citocinas inflamatorias.
WO2009001730A1 (ja) βセクレターゼ阻害活性を有する新規化合物

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08840979

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2009538227

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 12739795

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08840979

Country of ref document: EP

Kind code of ref document: A1